Literature DB >> 20207607

Weight gain and insulin resistance in children treated with valproate: the influence of time.

Fabio Masuccio1, Alberto Verrotti, Valentina Chiavaroli, Tommaso de Giorgis, Cosimo Giannini, Francesco Chiarelli, Angelika Mohn.   

Abstract

This study was undertaken in 2 parts to investigate the relationship between body size and insulin resistance during treatment with valproic acid in children. The cross-sectional part revealed differences in terms of body size and homeostasis model assessment of insulin resistance, which were higher in the group on medication. The longitudinal part showed a major increase in body size and insulin resistance during the first year of therapy. There was a subsequent decrease in insulin resistance in association with the rise of body size, however with a trend to level off. These results might be helpful to enhance the knowledge of valproic acid action on both insulin resistance and weight gain, allowing to plan appropriate approach for the prevention of the consequences of the treatment with valproic acid.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207607     DOI: 10.1177/0883073809349461

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

Review 1.  Epigenomic and transcriptional control of insulin resistance.

Authors:  E D Rosen
Journal:  J Intern Med       Date:  2016-10-14       Impact factor: 8.989

2.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

3.  Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA dehydrogenase in the metabolism of valproic acid: implications for the branched-chain amino acid oxidation pathway.

Authors:  Paula B M Luís; Jos P N Ruiter; Lodewijk Ijlst; Isabel Tavares de Almeida; Marinus Duran; Al-Walid Mohsen; Jerry Vockley; Ronald J A Wanders; Margarida F B Silva
Journal:  Drug Metab Dispos       Date:  2011-03-23       Impact factor: 3.922

Review 4.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

Review 5.  Nuclear Mechanisms of Insulin Resistance.

Authors:  Sona Kang; Linus T-Y Tsai; Evan D Rosen
Journal:  Trends Cell Biol       Date:  2016-01-25       Impact factor: 20.808

6.  Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.

Authors:  Lucy M Elphick; Nadine Pawolleck; Irina A Guschina; Leila Chaieb; Daniel Eikel; Heinz Nau; John L Harwood; Nick J Plant; Robin S B Williams
Journal:  Dis Model Mech       Date:  2011-10-14       Impact factor: 5.758

7.  The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia.

Authors:  Po-Sheng Wang; Shang-Liang Wu; Han-Yi Ching
Journal:  Int Clin Psychopharmacol       Date:  2014-07       Impact factor: 1.659

8.  Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis.

Authors:  Sona Kang; Linus T Tsai; Yiming Zhou; Adam Evertts; Su Xu; Michael J Griffin; Robbyn Issner; Holly J Whitton; Benjamin A Garcia; Charles B Epstein; Tarjei S Mikkelsen; Evan D Rosen
Journal:  Nat Cell Biol       Date:  2014-12-15       Impact factor: 28.824

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.